Legal status · United States
Is GDF15 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. GDF15 is not approved for any medical use in the United States. Its legal category is "Investigational, not approved". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 2 completed human trials are cited on its profile.
- People given it
- 313
- Found nothing
- 0
Legal category
Investigational, not approved
Natural GDF15 is not a drug. The drugs that target it, ponsegromab (which blocks it) and MBL949 (which mimics it), are investigational.
Reviewed Sep 2026. This is a legal category, not legal advice.
A "research use only" label on a vial does not make it legal to use on people.
GDF15 in the United States at a glance
| Legal category | Investigational, not approved |
|---|---|
| Note | Natural GDF15 is not a drug. The drugs that target it, ponsegromab (which blocks it) and MBL949 (which mimics it), are investigational. |
| FDA approval status | Not FDA-approved. No drug that mimics or blocks GDF15 is listed in the FDA drug database (Drugs@FDA) as of 11 September 2026. Ponsegromab, an antibody that blocks GDF15, is in combined mid-stage and final-stage studies for cancer cachexia, the weight and muscle loss that comes with cancer. MBL949, a drug that mimics GDF15, caused very little weight loss in a 2025 mid-stage study. |
| Studies in people | 6 of 10 sources on the profile |
| Reviewed | Sep 2026 |
The legal category and note come from the GDF15 profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.
What this means
- 01
GDF15 is being tested in registered clinical trials (official studies in people). FDA has not approved it for sale in the United States.
- 02
The only legal ways for a person to get it are to join a trial, or to use an official early-access program where one exists. There is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial supplies. That label does not make them legal to use in people.
What GDF15 is
GDF15 is a stress signal your body makes when cells are in trouble. It acts on the part of the brain that makes you feel sick and turn away from food. In 187 people with cancer who were wasting away, a drug that blocks it helped them gain 1.2 to 2.8 kg more than a dummy shot. A drug that boosts it, given to 126 adults with obesity, caused very little weight loss.
GDF15 is a stress signal. Your body makes more of it when cells are under strain.
How it works: In people, GDF15 goes up when cells are under almost any kind of stress. It runs high in people with cancer who are wasting away.
Approval history: Not FDA-approved. No drug that mimics or blocks GDF15 is listed in the FDA drug database (Drugs@FDA) as of 11 September 2026. Ponsegromab, an antibody that blocks GDF15, is in combined mid-stage and final-stage studies for cancer cachexia, the weight and muscle loss that comes with cancer. MBL949, a drug that mimics GDF15, caused very little weight loss in a 2025 mid-stage study.
How FDA treats this kind of product
Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.
The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for GDF15 on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.
GDF15 in sport and the military
Whether GDF15 is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up GDF15 by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.
- WADA Prohibited List
- Global DRO (check a named product)
- USADA (US athletes)
- Operation Supplement Safety (US service members)
The rules you compete or serve under decide this, not this page.
GDF15 in other countries
Frequently asked questions
Is GDF15 legal in the United States?
No. GDF15 is not approved for any medical use in the United States. Its legal category is "Investigational, not approved". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 2 completed human trials are cited on its profile. Note: Natural GDF15 is not a drug. The drugs that target it, ponsegromab (which blocks it) and MBL949 (which mimics it), are investigational.
Can I buy GDF15 in the United States?
There is no approved product to buy. In the United States, GDF15 has the legal category "Investigational, not approved". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything. Note: Natural GDF15 is not a drug. The drugs that target it, ponsegromab (which blocks it) and MBL949 (which mimics it), are investigational.
Is GDF15 FDA approved?
No. FDA status: Not FDA-approved. No drug that mimics or blocks GDF15 is listed in the FDA drug database (Drugs@FDA) as of 11 September 2026. Ponsegromab, an antibody that blocks GDF15, is in combined mid-stage and final-stage studies for cancer cachexia, the weight and muscle loss that comes with cancer. MBL949, a drug that mimics GDF15, caused very little weight loss in a 2025 mid-stage study.. Current US legal category: "Investigational, not approved". On the evidence, 2 completed human trials are cited on its profile.
Related compounds in the United States
Full research profile
How GDF15 works, the studies we cite, FDA status and the full legal summary are all on its compound profile.
GDF15 profileThis page is general information about the legal status of GDF15 in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.